AGL News and Press, agilon health inc. From 11/03/23

2023-11-03 10:02:39 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in For further details see: Cellectis, VYNE Therapeutics among healthcare movers

2023-11-03 08:22:27 ET More on pre-market losers stock Stocks To Watch: Tesla, Netflix, And AT&T Headline Big Week Of Earnings Acurx Pharma falls after mid-stage data for lead asset AstraZeneca to invest $245M in Cellectis to strengthen gene therapy portfolio ...

2023-11-02 16:07:52 ET More on agilon health agilon health: Improved Member Growth And Economies of Scale May Imply Undervaluation agilon health announces sale of MDX Hawaii Seeking Alpha’s Quant Rating on agilon health For further details see: agi...

Revenue increased 75% to $1.22 billion, Medicare Advantage membership increased 58% to 420,300, and total members live on the agilon platform grew to 508,000 Strong performance across core partner markets supported by membership growth and profitability gains in Medicare Advantage and...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

agilon health inc. (AGL) is expected to report $-0.05 for Q3 2023

2023-11-01 16:04:27 ET More on agilon health agilon health: Improved Member Growth And Economies of Scale May Imply Undervaluation agilon health: Strong Sales Growth, Lacks Remaining Value Drivers agilon health, inc. (AGL) Q2 2023 Earnings Call Transcript See...

Sale of MDX Hawaii enables agilon to focus on its full-risk partnership model in core partner markets agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it has sold MDX Hawaii, a wholly owned subsidiar...

RESEARCH DEMONSTRATES POTENTIAL OF THE PARSORTIX SYSTEM TO SUPPORT POWERFUL CHARACTERISATION OF CTCS IN HEAD AND NECK CANCER 41 key biomarkers including the immune checkpoint proteins PD-L1, CTLA4 and CD39 successfully evaluated Providing key information which could support the developm...

agilon REACH ACOs achieved $107 million in gross savings and 99.8% quality score agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $107 million in gr...